Stage 2 Breast Cancer Treatment Options Stage 3 Breast Cancer Treatment Options 2 min read Breast canceris a complex disease that’s different for every woman. Before you start a treatment, your doctor will want to know the size of the tumor and how far it has spread in your body, called...
Breast CancerRoses, D. F. (2005b). Systemic treatment for stage I and Stage II breast cancer. In C. A. Hudis & L. Norton (Eds.), Breast Cancer (2 ed., pp. 537-555). Philadelphia: Elsevier Churchill Livingstone. (Eds.), Breast Cancer (2 ed., pp. 567-573). Philadelphia: ...
Your doctor will think about a few things before they recommend a treatment for you: The type of breast cancer you have The size of your tumor and how far the cancer has spread in your body, called the stage of your disease Whether your tumor has things called receptors for HER2 protein...
Consensus statement: Treatment of early-stage breast cancer. J Natl Cancer Inst 11: 1-5, 1992 Google Scholar Lee HD, Suh CO, Jung WH, Oh KK, Park HB, Chi HS, Kim BR, Min JS: Partial mastectomy with axillary lymph node dissection and radiotherapy as a new treatment modality of ...
Tamoxifen (TAM) provides an effective agent for treatment of hormone-dependent breast cancer but resistance uniformly ensues upon continued use. Additional studies are required to define more precisely the mechanisms involved in developm... Berstein,L. - 《Endocrine Related Cancer》 被引量: 0发表: ...
Sara A. Hurvitz, MD, comments on her preferences for treating patients with HER2-positive metastatic breast cancer and shares her strategy for sequencing therapies. EP: 1.Treatment Options in HER2-Positive Metastatic Breast Cancer EP: 2.Tucatinib for HER2-Positive Metastatic Breast Cancer EP: 3....
Breast conserving treat- ment (BCT) for stage I-II breast cancer in elderly women: analysis of 927 cases. Crit Rev Oncol Hematol. 2009;71(1):79-88.Cutuli B, De Lafontan B, Vitali E, et al. Breast conserving treatment (BCT) for stage I-II breast cancer in elderly women: analysis ...
In this Review, we describe key steps in the development of the modern paradigm for the treatment of HER2-positive advanced-stage breast cancer, including selecting and sequencing new-generation HER2-targeted therapies, and summarize efficacy and safety outcomes from pivotal studies. We then outline ...
Army Medical Center Stage I and II Breast Cancer: A 5-Year Retrospective Treatment Evaluation At William Beaumont Army Medical CenterStage I and II Breast Cancer: A 5-Year Retrospective Treatment Evaluation At William Beaumont Army Medical CenterAn abstract is unavailable. This article is ava...
patients with high-risk stage 2/3 breast cancer received neoadjuvant datopotamab–deruxtecan, followed by sequential chemotherapy with or without targeted therapy, with the option of early surgical resection after each block of therapy. In a subgroup of patients, the sequential treatment strategy wa...